Who is the qualified person for pharmacovigilance (QPPV) and does the AI system replace them?

The QPPV is a mandatory regulatory role and the AI system supports - not replaces - their function. The system handles data collection, case processing, and report preparation; the QPPV provides medical assessment, signal interpretation, and formal regulatory sign-off. This dramatically increases the number of cases and signals a QPPV can manage without expanding headcount.

Does the system meet SAHPRA's electronic pharmacovigilance reporting requirements?

Yes. We configure direct electronic submission to SAHPRA's MedWatch reporting portal and South Africa's national pharmacovigilance centre (SA-ADR). For products with international registration, we also configure E2B(R3) ICH-standard electronic submissions for FDA, EMA, and other regulatory authorities.

What does an AI pharmacovigilance system cost for a South African pharmaceutical company?

AI PV systems for pharmaceutical companies typically range from R85,000 to R150,000+ for implementation depending on product portfolio size, safety database complexity, and international reporting scope. Most companies recover the investment within the first year from reduced PV headcount requirements and avoided compliance penalty exposure.

Can the system monitor social media and online forums for adverse event signals?

Yes. We deploy social media and online forum monitoring for product-specific adverse event mentions across South African platforms (Twitter/X, Facebook health groups, patient forums) - with NLP-based adverse event detection and triage integrated into the main case workflow. This is increasingly important as SAHPRA's expectations around digital source monitoring grow.

SAHPRA PV Regulations CompliantICH E2E Signal DetectionAutomated ICSR Processing

Detect Adverse Event Signals Before SAHPRA Detects Your Reporting Gaps

Manual adverse event case processing creates compliance risk, missed signals, and SAHPRA penalty exposure for South African pharmaceutical companies. Smart AI Solutions builds AI-powered pharmacovigilance systems - automated ICSR processing, real-time signal detection, and SAHPRA-compliant safety reporting.

"Our PV team was processing 40-60 cases per month manually for our 12-product portfolio. PSUR prepara…"

Dr Amina Pillay, Head of Drug Safety

Get My Custom AI Plan

Detect Adverse Event Signals Before SAHPRA Detects Your Reporting Gaps

Your Pharmacovigilance System Is a Manual Process in a Regulatory Environment That Demands Real-Time Detection

South African pharmaceutical companies have mandatory pharmacovigilance (PV) obligations under the Medicines and Related Substances Act and SAHPRA's pharmacovigilance guidelines - including individual case safety report (ICSR) submission timelines, periodic safety update reports (PSURs), and signal detection obligations. Meeting these obligations manually, across multiple product lines and safety data sources, creates systematic compliance risk.

SAHPRA requires 7-day reporting for fatal and life-threatening SARs (serious adverse reactions) - manual PV case processing regularly misses this window on complex cases, triggering regulatory findings
Adverse event reports arrive through multiple channels - healthcare providers, patients, clinical trials, literature, social media - and manual triage across these channels misses signals that AI-powered monitoring detects automatically
PSUR preparation requires aggregation of global safety data, literature review, and benefitrisk analysis across the product portfolio - a process consuming 4-8 weeks per product per cycle when done manually
Duplicate ICSR detection across multiple reporting sources is done manually - resulting in either under-reporting (missed cases) or over-reporting (duplicate submissions that inflate signal strength)
Signal detection requires statistical analysis of adverse event databases using standardised methods (PRR, ROR, Empirical Bayes) - which few SA PV teams have the statistical resource to perform at the required frequency

A Missed SAHPRA Safety Signal Can Result in a Licence Condition, Product Withdrawal, or Criminal Liability

SAHPRA's pharmacovigilance enforcement has intensified significantly since 2022. Companies that fail to detect and report safety signals in a timely manner face product licence conditions, enhanced post-marketing surveillance requirements, and in serious cases, criminal liability under the Medicines Act. The reputational and regulatory cost of a preventable signal detection failure vastly exceeds the investment in AI-powered PV automation.

7 days

SAHPRA reporting deadline for fatal SARs - missed routinely by manual PV teams processing complex multi-source cases

4-8 weeks

manual PSUR preparation time per product per cycle - AI-automated systems compress this to 5-7 working days

340%

increase in SAHPRA pharmacovigilance enforcement actions between 2020 and 2024

Illustrative example, not a client result.

Your AI Pharmacovigilance Platform

We build an integrated AI PV platform that automates ICSR intake and triage from all data sources, performs duplicate detection, generates case narratives, applies SAHPRA and ICH reporting rules, detects emerging safety signals, and produces PSUR documentation - dramatically reducing manual PV workload while improving compliance coverage.

Multi-Source ICSR Automation

The AI collects adverse event reports from all incoming channels - e-reporting portals, clinical trial safety data, medical literature, social media monitoring, and direct healthcare provider submissions - triage, deduplicates, and populates case records automatically for medical review.

Signal Detection & Statistical Analysis Engine

Automated disproportionality analysis (PRR, ROR, IC) runs continuously on your accumulated safety database, identifying emerging signals, quantifying their statistical strength, and presenting findings in SAHPRA and ICH E2E format - ready for your qualified person for pharmacovigilance (QPPV) to review.

Automated PSUR & DSUR Generation

Periodic Safety Update Reports and Development Safety Update Reports are assembled automatically from your cumulative safety data, with literature search integration, benefit-risk framework application, and pre-populated templates aligned to current ICH E2F and SAHPRA PSUR requirements.

Ready to implement this for your Pharmaceutical Companies?

Get My Custom AI Plan

"Our PV team was processing 40-60 cases per month manually for our 12-product portfolio. PSUR preparation took 6 weeks per product and we were at constant risk of missing the 7-day reporting window on complex cases. The AI pharmacovigilance system Smart AI Solutions built has reduced our case processing time by 70% and our PSUR cycle from 6 weeks to 8 days. We have not missed a single SAHPRA reporting deadline since implementation."

Dr Amina Pillay

Head of Drug Safety, Umvoti Pharmaceuticals, Durban

70%

Reduction in ICSR case processing time - enabling consistent 7-day SAR reporting compliance

8 days

PSUR preparation cycle - down from 6 weeks with manual processes

Zero

Missed SAHPRA reporting deadlines in the 18 months since AI PV platform deployment

Illustrative example, not a client result.

How It Works

PV System Audit & Safety Database Review (Weeks 1-2)

We audit your current PV processes, safety database, case workflow, and PSUR preparation methodology. We review your product portfolio, reporting obligations by market, and current QPPV structure to design the optimal AI platform configuration.

Platform Build, Data Migration & Validation (Weeks 3-7)

We build and configure the AI PV platform, migrate your historical safety database, configure reporting rules per product and market, and complete computer system validation to GXP standards. We integrate with your safety database (Argus, PVWORKS, or custom) and regulatory reporting channels.

QPPV Validation, Team Training & Go-Live (Weeks 8-10)

Your QPPV reviews the platform configuration and validates signal detection parameters. We train your PV team and medical affairs colleagues on case submission and review workflows. We go live with parallel processing for 4 weeks before full system handover.

Start My AI Journey

Ready to AI Pharmacovigilance?

Tell us about your business and we'll create a personalised AI automation plan.

Limited availability - we take on 4 new clients per month

SSL SecuredPOPIA CompliantNo-obligation consultationFree personalised AI plan

Your Email

About You

Your Goals

Frequently Asked Questions

Still have questions?

Our team answers every enquiry within one business day.

Book a Free Consultation WhatsApp Us

Our AI Services

Our Work

Service Locations